Journal of Enzyme Inhibition and Medicinal Chemistry · 2017 · 41 citations · 22 references
MedicineMedicinal ChemistryPharmacologyAntimicrobial PharmacologyDrug DiscoveryMolecular PharmacologyAntibacterial AgentsAntibacterial PharmacologyAntibacterial TherapyEnzyme InhibitionAntimicrobial Drug DevelopmentCarbonic Anhydrase FunctionCarbonic Anhydrase InhibitorsConcentrationImidazole ChemistryMechanism-based InhibitionNovel Antibacterial AgentsNovel Antibacterial Drug Discovery
We discovered novel and selective sulfonamides/amides acting as inhibitors of the α-carbonic anhydrase (CA, EC 4.2.1.1) from the pathogenic bacterium Vibrio cholerae (VchCA). This Gram-negative bacterium is the causative agent of cholera and colonises the upper small intestine where sodium bicarbonate is present at a high concentration. The secondary sulfonamides and amides investigated here were potent, low nanomolar VchCA inhibitors whereas their inhibition of the human cytosolic isoforms CA I and II was in the micromolar range or higher. The molecules represent an interesting lead for antibacterial agents with a possibly new mechanism of action, although their CA inhibition mechanism is unknown for the moment.
22
Claudiu T. Supuran, Andrea Scozzafava, Angela Casini · Medicinal Research Reviews · 2002 · 1.4K citations
Medicine, Biochemistry, Pharmacology +12
Updated Global Burden of Cholera in Endemic Countries
Mohammad Ali, Allyson R. Nelson, Anna Lena Lopez et al. · PLoS neglected tropical diseases · 2015 · 1.3K citations · Full text
Veterinary Medicine, Health Sciences, Infectious Diseases +17
Sonia Del Prete, Daniela Vullo, Gillian M. Fisher et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 322 citations · Full text